Teligent Total Long Term Liabilities 2010-2021 | TLGT
Teligent total long term liabilities from 2010 to 2021. Total long term liabilities can be defined as the sum of all non-current liabilities.
Teligent Annual Total Long Term Liabilities
(Millions of US $) |
| 2020 |
$175 |
| 2019 |
$196 |
| 2018 |
$140 |
| 2017 |
$121 |
| 2016 |
$112 |
| 2015 |
$103 |
| 2014 |
$145 |
| 2013 |
$3 |
| 2012 |
$1 |
| 2011 |
$1 |
| 2010 |
$0 |
| 2009 |
$0 |
Teligent Quarterly Total Long Term Liabilities
(Millions of US $) |
| 2021-06-30 |
$121 |
| 2021-03-31 |
$119 |
| 2020-12-31 |
$175 |
| 2020-09-30 |
$208 |
| 2020-06-30 |
$204 |
| 2020-03-31 |
$201 |
| 2019-12-31 |
$196 |
| 2019-09-30 |
$161 |
| 2019-06-30 |
$158 |
| 2019-03-31 |
$150 |
| 2018-12-31 |
$140 |
| 2018-09-30 |
$118 |
| 2018-06-30 |
$130 |
| 2018-03-31 |
$124 |
| 2017-12-31 |
$121 |
| 2017-09-30 |
$119 |
| 2017-06-30 |
$116 |
| 2017-03-31 |
$114 |
| 2016-12-31 |
$112 |
| 2016-09-30 |
$113 |
| 2016-06-30 |
$111 |
| 2016-03-31 |
$109 |
| 2015-12-31 |
$103 |
| 2015-09-30 |
$105 |
| 2015-06-30 |
$107 |
| 2015-03-31 |
$138 |
| 2014-12-31 |
$145 |
| 2014-09-30 |
$3 |
| 2014-06-30 |
$3 |
| 2014-03-31 |
$3 |
| 2013-12-31 |
$3 |
| 2013-09-30 |
$3 |
| 2013-06-30 |
$2 |
| 2013-03-31 |
$2 |
| 2012-12-31 |
$1 |
| 2012-09-30 |
$1 |
| 2012-06-30 |
$1 |
| 2012-03-31 |
$1 |
| 2011-12-31 |
$1 |
| 2011-09-30 |
$1 |
| 2011-06-30 |
$1 |
| 2011-03-31 |
$1 |
| 2010-12-31 |
$0 |
| 2010-09-30 |
$0 |
| 2010-06-30 |
$0 |
| 2010-03-31 |
$0 |
| 2009-12-31 |
$0 |
| 2009-09-30 |
$0 |
| 2009-06-30 |
$0 |
| 2009-03-31 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.000B |
$0.000B |
|
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
|
